AdaptHealth Corp. (AHCO) stock
AHCONasdaqServices-Home Health Care ServicesFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 6/3044% below fair value
$7.53−0.20 (-2.59%)
Close on Nov 17, 2026Market cap $1.03BP/E –Yield –
AdaptHealth ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
AdaptHealth's ebitda for the twelve months ending Jun 30, 2026 was $278.13M, down 55.0% year over year. For fiscal 2025 it was $472.80M, down 24.8% from the year before. The highest annual figure on record is $629.07M in fiscal 2024.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $472.80M | -24.8% |
| FY2024 | Dec 31, 2024 | $629.07M | – |
| FY2023 | Dec 31, 2023 | -$215.62M | -139.8% |
| FY2022 | Dec 31, 2022 | $541.59M | +12.0% |
| FY2021 | Dec 31, 2021 | $483.66M | +214.5% |
| FY2020 | Dec 31, 2020 | $153.79M | +67.3% |
| FY2019 | Dec 31, 2019 | $91.95M | – |
Quarterly ebitda
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$17.51M | -111.1% |
| Q1 FY2026 | Mar 31, 2026 | $111.96M | -4.7% |
| Q4 FY2025 | Dec 31, 2025 | $24.23M | -87.1% |
| Q3 FY2025 | Sep 30, 2025 | $159.45M | +3.4% |
| Q2 FY2025 | Jun 30, 2025 | $158.05M | +10.4% |
| Q1 FY2025 | Mar 31, 2025 | $117.52M | -18.1% |
| Q4 FY2024 | Dec 31, 2024 | $188.20M | – |
| Q3 FY2024 | Sep 30, 2024 | $154.25M | – |
| Q2 FY2024 | Jun 30, 2024 | $143.21M | -6.7% |
| Q1 FY2024 | Mar 31, 2024 | $143.41M | +19.5% |
| Q4 FY2023 | Dec 31, 2023 | -$125.44M | -197.2% |
| Q3 FY2023 | Sep 30, 2023 | -$363.73M | -350.4% |
| Q2 FY2023 | Jun 30, 2023 | $153.56M | +10.8% |
| Q1 FY2023 | Mar 31, 2023 | $119.99M | -6.7% |
| Q4 FY2022 | Dec 31, 2022 | $129.08M | -11.8% |
| Q3 FY2022 | Sep 30, 2022 | $145.28M | -0.2% |
| Q2 FY2022 | Jun 30, 2022 | $138.65M | +7.3% |
| Q1 FY2022 | Mar 31, 2022 | $128.58M | +105.4% |
| Q4 FY2021 | Dec 31, 2021 | $146.31M | – |
| Q3 FY2021 | Sep 30, 2021 | $145.54M | – |
| Q2 FY2021 | Jun 30, 2021 | $129.20M | – |
| Q1 FY2021 | Mar 31, 2021 | $62.62M | – |
See a number that looks wrong?